ADVERTISEMENT
ADVERTISEMENT
Learn How Researchers Make the Most of Viral Vectors for Gene Therapy
Viral Vector Platforms for Gene Therapy
In both the laboratory and clinic, scientists harness viral genetic transfer capabilities to develop gene therapies that modulate cellular function.
Viral Vector Platforms for Gene Therapy
Viral Vector Platforms for Gene Therapy

In both the laboratory and clinic, scientists harness viral genetic transfer capabilities to develop gene therapies that modulate cellular function.

In both the laboratory and clinic, scientists harness viral genetic transfer capabilities to develop gene therapies that modulate cellular function.

adenovirus

Learn about establishing a Gene Therapy Manufacturing Strategy 
Considerations for Gene Therapy Manufacturing Strategies
Thermo Fisher Scientific | Oct 24, 2022 | 1 min read
Discover tips for setting up and optimizing adeno-associated virus production.
Ribbon diagram of the protein coat of an adeno-associated virus
Preprints Propose Constellation of Causes for Kids’ Liver Disease
Christie Wilcox, PhD | Jul 25, 2022 | 2 min read
Two independent groups suggest the suite of recent unexplained hepatitis cases may stem from coinfection with an adeno-associated virus and a helper adeno- or herpesvirus, a duo which may be especially virulent in children with a particular genetic variant.
Brick building with tall windows and white letters out front that say "Food and Drug Administration"
FDA Limits Use of J&J Vaccine, Citing Safety Concerns
Natalia Mesa, PhD | May 6, 2022 | 2 min read
US adults are now only eligible for the vaccine under certain circumstances.
Liver glowing red underneath human torso
Mysterious Hepatitis Cases Reported in Young Children
Natalia Mesa, PhD | Apr 18, 2022 | 3 min read
Officials have ruled out known hepatitis viruses as the cause of a rash of illnesses in Europe and the US.
Optimize quality control in gene therapy viral vector production
Empty or Full: Separating Therapeutically Viable Viral Vectors
Bio-Techne | Mar 16, 2022 | 1 min read
How to detect impurities during gene therapy vector production
Improving Cancer Immunotherapy with Anti-Cancer Adenoviruses
The Scientist’s Creative Services Team and IsoPlexis | Jun 25, 2021 | 1 min read
Researchers use a mesenchymal stromal cell-based vector to deliver multiple viruses simultaneously to improve CAR-T cell anti-tumor activity.
Delivering Combination Immunotherapies to Solid Tumors
LabTalk Podcast - A Modern Trojan Horse: Delivering Combination Immunotherapies to Solid Tumors 
The Scientist’s Creative Services Team and IsoPlexis | Apr 26, 2021 | 1 min read
Katie McKenna discusses a combination CAR T and viral therapy that kills solid tumors.
Boosting CAR T Cell Therapy for Solid Tumors
The Scientist Creative Services Team in Collaboration with IsoPlexis | Apr 5, 2021 | 1 min read
Katie McKenna will discuss how oncolytic viral therapy enhances CAR-T cell killing of cancer cells.
Optimizing Adeno-Associated Virus (AAV) Manufacturing
The Scientist Creative Services Team in collaboration with OXGENE | Feb 16, 2021 | 2 min read
Scientists wield nature’s power to optimize adeno-associated virus (AAV) production and maximize gene therapy safety.
COVID-19, SARS-CoV-2, coronavirus, pandemic, Russia, vaccine, clinical trial, data, ethics, adenovirus, spike protein, Lancet
Scientists Voice Concerns over Russian COVID-19 Vaccine Study
Amanda Heidt | Sep 11, 2020 | 3 min read
Almost 40 scientists have signed an open letter, citing odd patterns in the data and a lack of transparency after authors withheld the full data.
adenovirus vector vaccine covid-19 pandemic coronavirus sars-cov-2 spike protein
Vector-Based Vaccines Come to the Fore in the COVID-19 Pandemic
Anthony King | Sep 8, 2020 | 6 min read
Adenovirus vectors deliver the genetic instructions for SARS-CoV-2 antigens directly into patients’ cells, provoking a robust immune response. But will pre-existing immunity from common colds take them down?
Chimp Viruses for Human Vaccines
Ruth Williams | Jan 4, 2012 | 3 min read
An adenovirus isolated from chimpanzee feces proves more effective than human adenoviruses as a vaccine vector for hepatitis C.
Virus Jumps Between Primates
Megan Scudellari | Jul 18, 2011 | 1 min read
In the first known case of a cross-species outbreak of an adenovirus, researchers identify a virus that infected both monkeys and humans.
ADVERTISEMENT